Fairmount Funds Management as of Sept. 30, 2023
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 20 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 19.7 | $164M | 2.3M | 69.89 | |
| Nuvalent Inc-a (NUVL) | 13.6 | $113M | 2.5M | 45.97 | |
| ImmunoGen | 11.3 | $94M | 5.9M | 15.87 | |
| Apogee Therapeutics (APGE) | 7.5 | $63M | 2.9M | 21.30 | |
| Merus N V (MRUS) | 5.3 | $44M | 1.9M | 23.58 | |
| Kiniksa Pharmaceuticals Com Cl A | 5.2 | $43M | 2.5M | 17.37 | |
| Argenx Se Sponsored Adr (ARGX) | 5.0 | $41M | 84k | 491.63 | |
| Cogent Biosciences (COGT) | 4.2 | $35M | 3.6M | 9.75 | |
| Soleno Therapeutics (SLNO) | 4.1 | $34M | 1.1M | 29.51 | |
| Enliven Therapeutics (ELVN) | 3.5 | $29M | 2.1M | 13.66 | |
| Immunovant (IMVT) | 3.5 | $29M | 750k | 38.39 | |
| Rayzebio | 3.3 | $27M | 1.2M | 22.20 | |
| Dianthus Therapeutics (DNTH) | 3.2 | $26M | 1.9M | 13.67 | |
| Miragen Therapeutics (VRDN) | 2.5 | $21M | 1.4M | 15.34 | |
| Tyra Biosciences (TYRA) | 2.3 | $19M | 1.4M | 13.77 | |
| Astria Therapeutics (ATXS) | 1.7 | $14M | 1.9M | 7.46 | |
| Trevi Therapeutics (TRVI) | 1.4 | $11M | 5.2M | 2.18 | |
| Terns Pharmaceuticals (TERN) | 1.2 | $10M | 2.0M | 5.03 | |
| Dbv Technologies Sa Sponsored Adr | 1.1 | $9.2M | 6.8M | 1.36 | |
| Aeglea Biotherapeutics Com New (SYRE) | 0.6 | $4.6M | 378k | 12.25 |
